Allakos (ALLK) News Today $0.33 0.00 (0.00%) As of 05/15/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ALLK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Allakos Completes Merger with Concentra BiosciencesMay 15, 2025 | tipranks.comAllakos And 2 Other Promising Penny Stocks To WatchApril 3, 2025 | finance.yahoo.comAllakos to be acquired by Concentra Biosciences for 33c per share in cashApril 2, 2025 | markets.businessinsider.comAllakos to be acquired by Concentra Biosciences for 33c per share in cashApril 2, 2025 | markets.businessinsider.com$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Allakos Inc. - ALLKApril 2, 2025 | prnewswire.comAllakos to Be Acquired for 33 Cents a ShareApril 2, 2025 | marketwatch.comAllakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per ShareApril 2, 2025 | markets.businessinsider.comALLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Allakos Inc. Is Fair to ShareholdersApril 2, 2025 | tmcnet.comShareholder Alert: The Ademi Firm Investigates Whether Allakos Inc. Is Obtaining a Fair Price for Its Public ShareholdersApril 2, 2025 | businesswire.comAllakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per ShareApril 2, 2025 | globenewswire.comAllakos Inc.: Hold Rating Amid Restructuring and Financial UncertaintyMarch 17, 2025 | tipranks.comAllakos faces potential Nasdaq delisting over share priceMarch 15, 2025 | investing.comAllakos Reports Q4 2024 Results Amid Strategic ShiftMarch 13, 2025 | tipranks.comAllakos Inc.: Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial ResultsMarch 13, 2025 | finanznachrichten.deAllakos reports Q4 EPS 0c, consensus (18c)March 12, 2025 | msn.comAllakos Provides Business Update and Reports Fourth Quarter 2024 Financial ResultsMarch 12, 2025 | globenewswire.comLycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology PipelineFebruary 11, 2025 | globenewswire.comKuehn Law Encourages Investors of Allakos Inc. to Contact Law FirmFebruary 10, 2025 | globenewswire.comAllakos Faces Strategic Uncertainty Following AK006 Phase 1 Trial Failure and Workforce ReductionJanuary 29, 2025 | markets.businessinsider.comAllakos cuts 75% of workforce after chronic hives trial failureJanuary 28, 2025 | finance.yahoo.comHold Rating on Allakos Amid Clinical and Financial Setbacks with AK006January 28, 2025 | markets.businessinsider.comAllakos downgraded to Market Perform from Outperform at JMP SecuritiesJanuary 28, 2025 | markets.businessinsider.comAllakos Shares Plummet to All-Time Low After Lead Candidate FailureJanuary 28, 2025 | marketwatch.comBay Area biotech firm Allakos, once worth $13B, lays off most of remaining workersJanuary 27, 2025 | msn.comAllakos To Drop Clinical Development Of AK006, Cut 75% Workforce; Stock Tanks In Pre-MarketJanuary 27, 2025 | markets.businessinsider.comAllakos to discontinue further clinical development of AK006, cut workforce 75%January 27, 2025 | markets.businessinsider.comAllakos stock hits 52-week low at $0.3 amid market challengesJanuary 27, 2025 | msn.comAllakos shares fall as Jefferies cuts price target to $0.40January 27, 2025 | msn.comWhy Is Allakos Stock Plunging On Monday?January 27, 2025 | benzinga.comAllakos Drops AK006, Cuts 75% of Staff After Study FailureJanuary 27, 2025 | marketwatch.comAllakos stock tumbles following AK006 trial discontinuationJanuary 27, 2025 | au.investing.comAllakos Restructures Amid AK006 Discontinuation and LayoffsJanuary 27, 2025 | tipranks.comAllakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces RestructuringJanuary 27, 2025 | globenewswire.comDiscover US Penny Stocks To Watch In January 2025January 22, 2025 | uk.finance.yahoo.comJMP Securities healthcare analysts hold an analyst/industry conference callJanuary 8, 2025 | markets.businessinsider.comPromising Outlook for Allakos’s AK006 in Treating Chronic Spontaneous Urticaria Justifies Buy RatingJanuary 8, 2025 | markets.businessinsider.comShort Interest in Allakos Inc. (NASDAQ:ALLK) Drops By 15.7%December 29, 2024 | marketbeat.comKuehn Law Encourages Investors of Allakos Inc. to Contact Law FirmDecember 19, 2024 | prnewswire.comPromising Potential of Allakos’s AK006 Drives Buy Rating Amidst Market Interest in Chronic Spontaneous UrticariaDecember 17, 2024 | markets.businessinsider.comFmr LLC Increases Stock Holdings in Allakos Inc. (NASDAQ:ALLK)December 14, 2024 | marketbeat.comPoint72 Asset Management L.P. Purchases New Position in Allakos Inc. (NASDAQ:ALLK)December 11, 2024 | marketbeat.comKuehn Law Encourages Investors of Allakos Inc. to Contact Law FirmDecember 9, 2024 | markets.businessinsider.comAllakos Reports Q3 2024 Results and Research ProgressNovember 22, 2024 | markets.businessinsider.comAllakos Inc. Alters Lease Agreement for Cost SavingsNovember 19, 2024 | markets.businessinsider.comLeerink Partnrs Increases Earnings Estimates for AllakosNovember 11, 2024 | marketbeat.comAllakos (ALLK) Gets a Hold from TD CowenNovember 8, 2024 | markets.businessinsider.comAllakos (ALLK) Gets a Sell from BarclaysNovember 8, 2024 | markets.businessinsider.comAllakos Runs Up Into A Near-Term CatalystNovember 7, 2024 | seekingalpha.comAllakos Provides Business Update and Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | globenewswire.comAllakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in OctoberOctober 28, 2024 | marketbeat.com Get Allakos News Delivered to You Automatically Sign up to receive the latest news and ratings for ALLK and its competitors with MarketBeat's FREE daily newsletter. Email Address ALLK Media Mentions By Week ALLK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALLK News Sentiment▼0.000.99▲Average Medical News Sentiment ALLK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALLK Articles This Week▼01▲ALLK Articles Average Week Get Allakos News Delivered to You Automatically Sign up to receive the latest news and ratings for ALLK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Protalix BioTherapeutics News Today BioHarvest Sciences News Today Genelux News Today Protara Therapeutics News Today Atossa Genetics News Today TuHURA Biosciences News Today Procaps Group News Today C4 Therapeutics News Today Anixa Biosciences News Today Milestone Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALLK) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allakos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allakos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
